Health Care·Pharmaceuticals·$17.0B
Viatris Inc. (VTRS) operates in the healthcare sector, focusing on pharmaceuticals....
Earnings Per Share (EPS)
EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.
Revenue Growth
Revenue growth reflects the company's ability to expand its market presence and drive sales, critical for future investments.
1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.
EPS Beat Streak
4Q
EPS Beat Rate
75%
Avg EPS Surprise
+4.32%
Avg Stock Reaction
+0.22%
In Q4 2025, Viatris reported an EPS of $0.57, exceeding expectations by 9.62%. However, the stock fell 5.16% the following day, indicating market concerns despite the positive earnings surprise.
Management Promises & Guidance
Overall, investors are cautiously optimistic about Viatris' upcoming earnings, especially after a series of positive EPS surprises in previous quarters.
Bull Case
If Viatris can demonstrate strong revenue growth and maintain or improve its EPS, it could signal robust operational performance and market confidence.
Bear Case
Conversely, any signs of declining revenue or increased operational challenges could lead to a negative market reaction, especially given the recent stock performance.
Earnings Per Share (EPS)
N/AEPS is a key indicator of the company's profitability and financial health, which investors closely monitor.
Revenue Growth
N/ARevenue growth reflects the company's ability to expand its market presence and drive sales, critical for future investments.
Market Share in Key Therapeutic Areas
N/AUnderstanding market share helps gauge competitive positioning and potential for growth within the pharmaceutical industry.
The print will turn on these two things.
Q1
What is the expected EPS and revenue growth for this quarter?
These figures will significantly influence investor sentiment and stock performance, especially following recent earnings surprises.
Q2
How is Viatris addressing competitive pressures in key therapeutic areas?
Understanding the company's strategy in a competitive landscape will provide insights into its future growth potential.
Why consensus could be wrong
The Street may be underestimating Viatris' ability to leverage its global presence for revenue growth despite competitive pressures.
Supporting Evidence
Historically, Viatris has consistently beaten EPS estimates, suggesting stronger underlying performance than anticipated.
The options market is pricing in an 8.1% move, indicating higher volatility than usual, which may not align with the company's stable fundamentals.
Key Risk
If the company reports an unexpected increase in market share or revenue growth, it could challenge current bearish sentiments.
Pre-commit to what would confirm each case.
The market is weighing the company's ability to sustain growth amidst competitive pressures and operational challenges.
Bull Confirmed If
An EPS growth of over 10% compared to last quarter would confirm strong operational performance.
Bear Confirmed If
An EPS decline or revenue stagnation would indicate potential challenges in the business.
Implied Move
±8.1%
Historical Avg
±8.0%
The options market is pricing in a significant move, reflecting uncertainty about the earnings report.
Options are pricing ±8.1% while VTRS has averaged ±8.0% over the last 8 prints — setup is roughly in line with history.
Likely market behavior by outcome — not investment advice.
Beat & Raise
If Viatris beats expectations, history suggests a potential stock increase of around 3.7%, confirming positive market sentiment.
In-Line / Cautious
If results are in line with expectations, the stock may experience muted movement as investors await further commentary from management.
Miss
A miss could lead to a decline of approximately 10.1% based on historical patterns, reflecting investor disappointment.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
PARAMOUNT SKYDANCE C Class B
May 4, 2026